Stem Cell News

Stem-Cell Clinical Trials Move Debate Beyond Labs

11 October 2011

Professor Pete Coffey (UCL Institute of Ophthalmology), in collaboration with Pfizer, is awaiting regulatory permission to begin an embryonic stem cell trial to treat age-related macular degeneration.

Prof Pete Coffey

More at The Wall Street Journal

Page last modified on 11 oct 11 14:20